so in one corner we have the 'need a cap raise' as PR can't deliver a deal and we will be diluted into oblivion.
in the other we have the fda go ahead will catalyse a deal with a nice upfront.
time will clearly tell but whilst a cap raise may come I see no credible way to raise their current market cap or more in cash in the foreseeable future, it's just too much. Scott Williams is there for a reason and I would hope / expect the much talked about 32 data room BPs to get more interested once we get an fda go ahead. don't forget about royalty deals etc etc, nor the options funding.
the company has run this far too close for my liking and I'm exhausted by this investment but I trust in the science and in the greed of BP to see a 98% chance of success for a blockbuster drug and start bidding.
personally I'm feeling happy I averaged down in the mid 20s.
it will be a fascinating 2-3 months
PAR Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)